European Pharmacopoeia / Ph. Eur. Commission | News | 13 February 2019 | Strasbourg, France
The EDQM is renewing its call for expressions of interest to join the European Pharmacopoeia (Ph. Eur.) as an independent scientific expert. Professionals from national authorities (e.g. pharmacopoeial authorities, official medicines control laboratories, licensing authorities and inspectorates), the private sector (pharmaceutical or chemical industries), academia, research organisations and...
European Pharmacopoeia / Monograph | News | 25 January 2019 | Strasbourg, France
A revised version of the monograph on Oxytetracycline hydrochloride (0198) has been adopted by the European Pharmacopoeia Commission and will be published in the upcoming 10th Edition. This revised version will include impurity F as a specified impurity and will introduce a limit of maximum 1.0% for the sum of impurities D, E and F, changes seen as a temporary solution that would alleviate the...
Products and Services | News | 24 January 2019 | Strasbourg, France
The 9.8 supplement of European Pharmacopoeia is now available and will be applicable in 38 European countries as from 01 July 2019.
European Pharmacopoeia / Public enquiry | News | 17 January 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission has launched a public consultation on how the current situation with dissolution testing in Ph. Eur. Finished Products Monographs (FPMs) could be improved.
European Pharmacopoeia / Monograph | News | 15 January 2019 | Strasbourg, France
The EDQM wishes to inform stakeholders that the monograph for Octreotide (2414) will be published in the 10th Edition of the European Pharmacopoeia and will become effective on 1 January 2020.
European Pharmacopoeia / General | News | 14 January 2019 | Strasbourg, France
Monographs and general texts on radiopharmaceutical preparations are elaborated by experts in the field. In order to guide experts on the information to be included in European Pharmacopoeia (Ph. Eur.) monographs, and also to harmonise the style of the different monographs, a Guide for the elaboration of monographs on radiopharmaceuticals was published by the EDQM in 2010.
European Pharmacopoeia / Ph. Eur. Commission | News | 14 January 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) Commission has decided to replace the Histamine Sensitisation Test “HIST” (test in mice) with a standardised CHO cell clustering assay (in vitro cell-based test) for residual pertussis toxin testing in acellular pertussis vaccines, as of next year. The introduction of a standardised CHO cell-clustering assay for residual pertussis toxin testing is based on...
European Pharmacopoeia / Public enquiry | News | 09 January 2019 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) has launched a public consultation on a new general chapter, 2.6.32. Test for bacterial endotoxins using recombinant factor C (rFC). This is not a new topic for the Ph. Eur. which was one of the first pharmacopoeias to refer to rFC, namely in chapter 5.1.10 Guidelines for using the test for bacterial endotoxins in Supplement 8.8 (2016), allowing the...